GSK-923295 5mg 5mg | Purity Not Available
Adooq Bioscience
GSK-923295, is a small-molecule inhibitor of the mitotic kinesin centromere-associated protein E, (CENP-E).
More Information Supplier PageSearch Results
GSK-923295 25mg 25mg | Purity Not Available
Adooq Bioscience
GSK-923295, is a small-molecule inhibitor of the mitotic kinesin centromere-associated protein E, (CENP-E).
More Information Supplier PageGSK-923295 10mM * 1mL in DMSO 10mM * 1mL in DMSO | Purity Not Available
Adooq Bioscience
GSK-923295, is a small-molecule inhibitor of the mitotic kinesin centromere-associated protein E, (CENP-E).
More Information Supplier PageGSK-923295 10mg 10mg | Purity Not Available
Adooq Bioscience
GSK-923295, is a small-molecule inhibitor of the mitotic kinesin centromere-associated protein E, (CENP-E).
More Information Supplier PageFMK 50mg 50mg | Purity Not Available
Adooq Bioscience
FMK is potent, highly specific and irreversible inhibitor of p90 ribosomal protein S6 kinase RSK1 and RSK2; Fmk binds in the CTKD ATP-binding site and inhibits RSK autophosphorylation at Ser386. Fmk induces significant apoptosis in human FGFR3-expressing, t(4;14)-positive multiple myeloma cells.
More Information Supplier PageFMK 5mg 5mg | Purity Not Available
Adooq Bioscience
FMK is potent, highly specific and irreversible inhibitor of p90 ribosomal protein S6 kinase RSK1 and RSK2; Fmk binds in the CTKD ATP-binding site and inhibits RSK autophosphorylation at Ser386. Fmk induces significant apoptosis in human FGFR3-expressing, t(4;14)-positive multiple myeloma cells.
More Information Supplier PageFMK 25mg 25mg | Purity Not Available
Adooq Bioscience
FMK is potent, highly specific and irreversible inhibitor of p90 ribosomal protein S6 kinase RSK1 and RSK2; Fmk binds in the CTKD ATP-binding site and inhibits RSK autophosphorylation at Ser386. Fmk induces significant apoptosis in human FGFR3-expressing, t(4;14)-positive multiple myeloma cells.
More Information Supplier PageFMK 10mg 10mg | Purity Not Available
Adooq Bioscience
FMK is potent, highly specific and irreversible inhibitor of p90 ribosomal protein S6 kinase RSK1 and RSK2; Fmk binds in the CTKD ATP-binding site and inhibits RSK autophosphorylation at Ser386. Fmk induces significant apoptosis in human FGFR3-expressing, t(4;14)-positive multiple myeloma cells.
More Information Supplier PageGW 5074 10mg 10mg | Purity Not Available
Adooq Bioscience
GW 5074 is a potent, selective and cell-permeable c-Raf1 kinase inhibitor
More Information Supplier PageGW 5074 100mg 100mg | Purity Not Available
Adooq Bioscience
GW 5074 is a potent, selective and cell-permeable c-Raf1 kinase inhibitor
More Information Supplier Page